CDTX — CIDARA THERAPEUTICS INC

Ownership history in BVF INC/IL · 6 quarters on record

This page tracks every 13F SEC filing in which BVF INC/IL reported a position in CIDARA THERAPEUTICS INC (CDTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

5.49% (2025 Q3)

Avg. % of fund

1.5%

First filed

2024 Q2

Last filed

2025 Q3

Quarters held

6

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q3	ADDED	1,414,165	+627,773	+79.8%	5.49%	$135.4M	—
2025 Q2	REDUCED	786,392	-138,250	-15.0%	1.37%	$38.3M	—
2025 Q1	REDUCED	924,642	-168,154	-15.4%	0.81%	$19.9M	—
2024 Q4	ADDED	1,092,796	+389,731	+55.4%	1.00%	$29.4M	—

% of Fund (quarterly)

Other funds also holding CDTX

As of 2025 Q4 — sorted by position size

Velan Capital Investment Management LP 3Y 13.89% Vivo Capital, LLC 3Y 7Y 13.66% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 13.37% Beryl Capital Management LLC 3Y 7Y 11.69% SUPERSTRING CAPITAL MANAGEMENT LP 10.06% FNY Investment Advisers, LLC 3Y 7Y 9.07% OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3Y 7Y 8.12% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 7.62% Sand Grove Capital Management LLP 3Y 7Y 6.05% Chicago Capital Management, LLC 3Y 7Y 5.56%

← Back to BVF INC/IL Holdings